Pulmonary arterial hypertension (PAH) is a devastating disease characterized by arteriopathy in the small to medium-sized distal pulmonary arteries, often accompanied by infiltration of inflammatory ...

Hypertension is one of the most prevalent non-transmittable diseases in the world, with 29% of the world's population expected to suffer from the condition by 2025. Despite substantial advances in ...

Hypertension is a major modifiable risk factor for renal, cerebrovascular, and cardiovascular disease. The pathophysiology of hypertension, also known as high blood pressure, is complex, whereby both ...

Laragh also played a pivotal part in elucidating the role of aldosterone in the pathogenesis of malignant hypertension and CV disease in general. [10,11] He was an outstanding clinician-scientist who ...

Expert Rev Cardiovasc Ther. 2012;10(11):1367-1373. The elderly merit special consideration for BP measurement. These hypertensive patients are prone to have autonomic failure with postural hypotension ...

Pulmonary arterial hypertension (PAH), characterized by elevated blood pressure in the pulmonary artery, is a rare condition that disproportionately affects women. Over the last decade, a greater ...

Although some cases of PAH have known causes, such as genetic factors, many cases have no identifiable underlying cause and are designated as idiopathic. Early diagnosis and treatment are critical for ...

CHICAGO, IL—Use of an investigational endothelin receptor antagonist in patients with resistant hypertension has a significant impact on both automated office and 24-ambulatory blood pressure when ...

Body composition—the distribution of bone, muscle, and fat in the body—can yield vital information on the metabolic and nutritional status of a patient. Several studies have demonstrated the impact of ...